LIGAND PHARMACEUTICALS INCORPORATED Deferred Tax Liabilities, Gross
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) had Deferred Tax Liabilities, Gross of $86.12 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-02-27
- 2025-12-31: Deferred Tax Liabilities, Gross $86.12M.
- 2024-12-31: Deferred Tax Liabilities, Gross $73.14M.
- 2023-12-31: Deferred Tax Liabilities, Gross $77.47M.
- 2022-12-31: Deferred Tax Liabilities, Gross $75.58M.
| Period end | Deferred Tax Liabilities, Gross | Deferred Tax Liabilities, Gross as first filed |
|---|---|---|
| 2025-12-31 | $86.12M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $73.14M 10-K · filed 2026-02-27 | |
| 2023-12-31 | $77.47M 10-K · filed 2025-02-28 | |
| 2022-12-31 | $75.58M 10-K · filed 2024-02-29 | |
| 2021-12-31 | $72.31M 10-K · filed 2023-02-28 | $111.52M 10-K · filed 2022-02-28 |
| 2020-12-31 | $124.30M 10-K · filed 2022-02-28 | |
| 2019-12-31 | $51.71M 10-K · filed 2021-02-24 | $50.11M 10-K · filed 2020-02-27 |
| 2018-12-31 | $51.97M 10-K · filed 2020-02-27 | |
| 2017-12-31 | $51.63M 10-K · filed 2019-02-28 |